Skip to main content
Fig. 4 | Journal for ImmunoTherapy of Cancer

Fig. 4

From: Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Fig. 4

Enadenotucirev DNA detection in samples of epithelial tumors by qPCR (all cohorts). The exploratory qPCR analysis in patients with CRC and other tumor types provides supporting evidence demonstrating that enadenotucirev can be delivered to several different carcinoma types by IV infusion. Individual patient data are shown with corresponding identification in the key

Back to article page